Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a Tertiary care hospital
JPMA-Journal of Pakistan Medical Association. 2004; 54 (1): 17-20
em Inglês
| IMEMR
| ID: emr-175582
ABSTRACT
Objective:
To evaluate the response of Imatinib mesylate in patients with myeloid leukemia in chronic, accelerated and blast phase
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
J. Pak. Med. Assoc.
Ano de publicação:
2004
Similares
MEDLINE
...
LILACS
LIS